SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma gets USFDA nod for CNS drug

02 Jun 2011 Evaluate

Aurobindo Pharma Ltd has received the final approval from the US Food and Drug Administration (US FDA) for Donepezil Hydrochloride tablets. Donepezil hydrochloride tablet is the generic equivalent to Aricept tablets Eisai Medical Research Inc.

They are indicated for the treatment of mild, moderate, and severe dementia of the Alzheimer's type and fall under the Central Nervous System therapeutic segment. The product had a market size of approximately $2.5 billion for the 12 months ended September 2010 and the product would be launched soon.

crackcrack

Aurobindo Pharma Share Price

1488.50 9.95 (0.67%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×